Document is current
Any future updates will be listed below
-
Authors
Sivapalan, Pradeesh https://orcid.org/0000-0002-8620-3655
Rutishauser, Jonas
Ulrik, Charlotte Suppli
Leuppi, Jörg D.
Pedersen, Lars
Mueller, Beat
Eklöf, Josefin
Biering-Sørensen, Tor
Gottlieb, Vibeke
Armbruster, Karin
Janner, Julie
Moberg, Mia
Lapperre, Therese S.
Nielsen, Thyge L.
Browatzki, Andrea
Mathioudakis, Alexander
Vestbo, Jørgen
Schüetz, Philipp
Jensen, Jens-Ulrik
-
Funding
Funding for this research was provided by:
Sundhed og Sygdom, Det Frie Forskningsråd (6110-00268B)
The Danish Regions Medical Fund (5894/16)
- License Information
-
More Information
Article History
Received: 26 February 2021
Accepted: 13 May 2021
First Online: 21 May 2021
Declarations
:
: CORTICO-COP was approved by the ethics committees of all participating sites (H-15012207). The Danish Medicines Agency (EudraCT Number 2015-003441-26) and the Danish Data Protection Agency (HGH-2015-038 and I-Suite number 04014). REDUCE was approved by the ethics committees of all participating sites (Project Number: EKBB_167/05) and the Swiss Agency for Therapeutic Products (Swissmedic; project number: 2006DR4021). The trial was registered with ISCRTN (isrctn.org identifier: ISRCTN19646069). Written informed consent was obtained from patients before randomisation from both trials.
: Not applicable.
: All authors have completed the ICMJE uniform disclosure form, describing any conflicts of interest. None of the authors have any conflicts of interest that are directly related to this work.
